Loading organizations...
Loading organizations...
Clinical stage biopharmaceutical company addressing unmet medical needs.
Eccogene has raised $25.2M across 1 funding round.
Eccogene has raised $25.2M in total across 1 funding round.
Eccogene has raised $25.2M in total across 1 funding round.
Eccogene's investors include New Alliance Capital, Zhangjiang Healthcare Venture Capital, Delos Capital, Rockbleu Capital, YuFu Investment.
Eccogene has raised $25.2M across 1 funding round. Most recently, it raised $25.2M Series B in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 12, 2023 | $25.2M Series B | New Alliance Capital, Zhangjiang Healthcare Venture Capital | Delos Capital, Rockbleu Capital, YuFu Investment |